author-photo

N. Stojkowitz

6

Papers

36

Citations

Citation Trend

Filter By

Papers (5) Sort By

Journal Conference Others

1213PSingle intravenous preoperative administration of the oncolytic virus Pexa-Vec to prime anti-tumour immunity

2019 Annals of Oncology
Show All
- Source
- Cite
- Save
Citations (1)
Vaccinia-based oncolytic immunotherapy Pexastimogene Devacirepvec in patients with advanced hepatocellular carcinoma after sorafenib failure: a randomized multicenter Phase IIb trial (TRAVERSE)

2019 OncoImmunology
Show All
- Source
- Cite
- Save
Citations (33)
110TiPA phase I dose escalation trial evaluating the impact of an in situ immunization strategy with intra-tumoral injections of Pexa-Vec in combination with ipilimumab in advanced solid tumors with injectable lesions

2018 Annals of Oncology
Show All
- Source
- Cite
- Save
Citations (0)
Randomisierte Phase-IIb-Studie mit Pexa-Vec (pexastimogene devacirepvec; JX-594), eine onkolytische Immuntherapie mit Best Supportive Care (BSC) gegen BSC allein bei Patienten mit Leberzellkarzinom (HCC) und fehlgeschlagener Sorafenib-Behandlung (TRAVERSE)

2015 Zeitschrift Fur Gastroenterologie
Show All
- Source
- Cite
- Save
Citations (1)
2219 Intratumoral injection of the oncolytic immunotherapeutic Pexa-Vec (JX-594) in liver tumors and hepatocellular carcinoma: Recommendations for clinical practice

2015 European Journal of Cancer
Show All
- Source
- Cite
- Save
Citations (0)